Ann: BGD: Response to Marmota Limited (ASX.MEU) Announcement, page-35

First 35 Last

Share
Profile

Follow
greenmachine05

41 Posts.

2

14/07/23

15:23

Post #: 68793054
Share

Originally posted by BaltasarG: ↑

Missed this little gem mate. Ponzi hey?

So MEU moves at the pace of cold molasses, and has gone from uranium to gold to REE. Smells like a lifestyle company mate. That's just the facts that even a novice investor can see.

BGD lists and within 2 years grows a resource at ridiculously cheap cost per oz, has a high grade blend to mix with and owns the only mill in the region and had access to excellent funding sources due to Alex's pedigree and the A team he"s assembled.

Like a couple of mining colleagues in WA stated, the legal claim is more about leveraging off the success of others. MEU assets are stranded without BGD.

So here's the thing, either way this legal claim loses for MEU. They need BGD not the other way around. The share register is already looser than a hooker on a troop train and imagine the dilution for funding any processing without using BGD assets in the region. Not a smart play.

Once this all blows up in MEUs face they may not get favourable terms for processing going forward. Not a very strategic play now is it. Stranded.

For your sakes I hope the next CR isn't down at the 2c mark as I don't see this company having the same level of connections and confidence/support from the market like the recent BGD raise.

Something to ponder, is your hard earned gonna give you a better return elsewhere in the coming commodities pump back half ofnthsis year. My guess is YES.

Best of luck.

Expand

Out of interest , what is alex's pedigree in developing or advancing projects is there any other companies he has done that can be pointed to?

MEU Price at posting: 3.6¢ Sentiment: Hold Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 6 more messages in this thread...

First 35 Last

Add MEU (ASX) to my watchlist

(20min delay)
Last 3.6¢		Change 0.000(0.00%)		Mkt cap ! $39.11M

Open	High	Low	Value	Volume
3.6¢	3.6¢	3.6¢	$32.31K	897.5K

Buyers (Bids)

No.	Vol.	Price($)
1	499751	3.6¢

Sellers (Offers)

Price($)	Vol.	No.
3.8¢	334801	3

View Market Depth

No.	Vol.	Price($)
1	499751	0.036
5	376274	0.035
5	674117	0.034
2	175000	0.033
4	164960	0.032

Price($)	Vol.	No.
0.038	334801	3
0.039	329982	2
0.040	232888	3
0.041	13562	1
0.042	50000	1

Last trade - 14.08pm 07/10/2024 (20 minute delay)

MEU (ASX) Chart

Ann: BGD: Response to Marmota Limited (ASX.MEU) Announcement, page-35

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: BGD: Response to Marmota Limited (ASX.MEU) Announcement, page-35

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News